| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700213 | 雷莫芦单抗注射液 | ramucirumab | Injection | Biological Products(2) | New Drug Application | 2018-03-05 | 正大天晴药业集团南京顺欣制药有限公司 | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | Certificate Issued | 2018-07-13 | view |
| JTS1900029 | 雷莫芦单抗注射液 | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2019-06-25 | Lilly France | Lilly France | Certificate Issued | 2019-07-25 | view |